Express News | Geneoscopy: Confident Litigation Will Not Delay Commercial Launch of Colosense

BreakingsJul 1 20:18

Express News | Geneoscopy: Files Counterclaims Against Exact Sciences

BreakingsJul 1 20:17

Exact Sciences Initiated at Sector Outperform at Scotiabank on Advanced Diagnostics

Seeking AlphaJun 28 05:29

Exact Sciences Initiated at Sector Outperform by Scotiabank

Exact Sciences Initiated at Sector Outperform by Scotiabank

Dow JonesJun 27 21:12

Jefferies Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $75

Jefferies analyst Tycho Peterson maintains $Exact Sciences(EXAS.US)$ with a buy rating, and maintains the target price at $75.According to TipRanks data, the analyst has a success rate of 55.3% and a

Futu NewsJun 27 20:31 · Ratings

Scotiabank Initiates Exact Sciences at Sector Outperform With $70 Price Target

Exact Sciences (EXAS) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $66 to $100. Price: 44.00, Change: -0.16, Percent Change: -0.36

MT NewswiresJun 27 19:42